Investigation and a potential class action lawsuit against Wyeth and others related to the sale of ProMeris.
ProMeris is a topical treatment for fleas and ticks that is sold for use on cats and dogs as young as eight weeks old. This investigation focuses on allegations that ProMeris is not effective in controlling flea and tick outbreaks, and may contains ingredients that can result cause vomiting, drooling, disorientation, skin irritation, spasms, and other adverse health effects on pets. If you have purchased ProMeris for use on a cat or dog, please contact the attorneys below.
Name (Stock Symbol)
Wyeth is a pharmaceutical company. It is now a subsidiary of Pfizer.
The information provided on ClassAdvocate.com is general in nature,
does not apply to any particular factual situation, and is not and
should not be taken as legal or other professional advice. We make no
commitment or warranty that the factual, legal or any other information
on ClassAdvocate.com, or on any linked website, is accurate, complete,
error-free, or current. As such, you should not rely on such information,
and should seek professional advice if and as you determine appropriate.
ClassAdvocate.com is not a lawyer referral service, and no attorney-client
or confidential relationship is or should be formed by use of the site.
The investigations listed on ClassAdvocate.com are attorney advertisements
and do not in any way constitute a referral or endorsement by ClassAdvocate.com
or any approved or authorized lawyer referral service.